Cytomel and Fenofibrate drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Cytomel (liothyronine sodium) and Fenofibrate (fenofibrate). Common drug interactions include chronic kidney disease among females and asthenia among males.

The phase IV clinical study analyzes what interactions people have when they take Cytomel and Fenofibrate. It is created by eHealthMe based on reports of 33 people who take the same drugs from the FDA, and is updated regularly.

What is Cytomel?

Cytomel has active ingredients of liothyronine sodium. It is often used in hypothyroidism. eHealthMe is studying from 7,595 Cytomel users. Check the latest studies of Cytomel.

What is Fenofibrate?

Fenofibrate has active ingredients of fenofibrate. It is often used in high blood cholesterol. eHealthMe is studying from 40,456 Fenofibrate users. Check the latest studies of Fenofibrate.

On Jul, 19, 2026

33 people who take Cytomel and Fenofibrate together, and have interactions are studied.

Cytomel and Fenofibrate drug interactions.

What are the common drug interactions of Cytomel and Fenofibrate, by gender? *:

female:

Chronic kidney disease
Diarrhoea
Depression
Insomnia (sleeplessness)
Serum sickness (hypersensitivity reaction that results from the injection of heterologous or foreign protein or serum)
Sleep apnoea syndrome (a sleep-related disorder in which the effort to breathe is diminished or absent)
Visual impairment
Abdominal discomfort
Abdominal pain
Dyslexia (disorders that involve difficulty in learning to read or interpret words, letters, and other symbols)

male:

Asthenia (weakness)
Blood glucose decreased
Acute coronary syndrome (acute chest pain and other symptoms that happen because the heart does not get blood)
Cough
Myocardial infarction (destruction of heart tissue resulting from obstruction of the blood supply to the heart muscle)
Nasal congestion (blockage of the nasal passages usually due to membranes lining the nose becoming swollen from inflamed blood vessels)
Blood pressure increased
Chronic kidney disease
Hypersensitivity
Malaise (a feeling of general discomfort or uneasiness)

What are the common drug interactions of Cytomel and Fenofibrate, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

Chronic kidney disease
Hepatic enzyme increased
Hypertension (high blood pressure)
Depression
Gastrooesophageal reflux disease (stomach contents (food or liquid) leak backwards from the stomach into the oesophagus)
Nephrogenic anaemia (anaemia due to kidney disease)
Renal failure (kidney dysfunction)

50-59:

Asthenia (weakness)
Blood glucose decreased
Blood glucose fluctuation
Diarrhoea
Dizziness
Gait disturbance
Hypoglycaemia (deficiency of glucose in the bloodstream)
Neuropathy peripheral (surface nerve damage)
Paraesthesia (sensation of tingling, tickling, prickling, pricking, or burning of a person's skin with no apparent long-term physical effect)
Sinus disorder (disease of sinus)

60+:

Abdominal distension
Arrhythmia (irregular heartbeat)
Palpitations (feelings or sensations that your heart is pounding or racing)
Poor quality sleep
Pulmonary congestion (congestion in the lungs)
Thyroxine decreased
Tri-iodothyronine increased
Weight increased
Cardiac failure
Cardiac flutter (abnormal heart rhythm)

What are the existing conditions these people have? *

Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 10 people, 30.30%
Cataplexy (loss of muscle tone accompanied by full conscious awareness): 10 people, 30.30%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 7 people, 21.21%
High Blood Pressure: 5 people, 15.15%
Lipodystrophy Acquired (a regional loss of subcutaneous adipose tissue which usually starts in the face, extends downward acquired): 5 people, 15.15%
Pain: 4 people, 12.12%
Depression: 4 people, 12.12%
Thyroid Diseases: 3 people, 9.09%
Cardiac Failure: 3 people, 9.09%
Weakness: 3 people, 9.09%

* Approximation only. Some reports may have incomplete information.

Do you take Cytomel and Fenofibrate?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously